Advantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantation
Authors:
Open Access
- 1 February 2015
- journal article
- research article
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. 9, 1217-24
Abstract
Advantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantation Matthias Helmschrott,1 Rasmus Rivinius,1 Arjang Ruhparwar,2 Bastian Schmack,2 Christian Erbel,1 Christian A Gleissner,1 Mohammadreza Akhavanpoor,1 Lutz Frankenstein,1 Philipp Ehlermann,1 Tom Bruckner,3 Hugo A Katus,1 Andreas O Doesch1 1Department of Cardiology, Angiology, Pneumology, 2Department of Cardiac Surgery, 3Institute for Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany Background: Nephrotoxicity is a serious adverse effect of calcineurin inhibitor therapy in patients after heart transplantation (HTX).Aim: In this retrospective registry study, renal function within the first 2 years after HTX in patients receiving de novo calcineurin inhibitor treatment, that is, cyclosporine A (CSA) or tacrolimus (TAC), was analyzed. In a consecutive subgroup analysis, renal function in patients receiving conventional tacrolimus (CTAC) was compared with that of patients receiving extended-release tacrolimus (ETAC).Methods: Data from 150 HTX patients at Heidelberg Heart Transplantation Center were retrospectively analyzed. All patients were continuously receiving the primarily applied calcineurin inhibitor during the first 2 years after HTX and received follow-up care according to center practice.Results: Within the first 2 years after HTX, serum creatinine increased significantly in patients receiving CSA (PKeywords
This publication has 31 references indexed in Scilit:
- Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimenDrug Design, Development and Therapy, 2014
- Improved Kidney Graft Function After Conversion From Twice Daily Tacrolimus to a Once Daily Prolonged-Release FormulationTransplantation Proceedings, 2011
- Rapid Decline in Glomerular Filtration Rate during the First Weeks Following Heart TransplantationTransplantation Proceedings, 2011
- A prospective randomized study comparing cyclosporine versus tacrolimus combined with daclizumab, mycophenolate mofetil, and steroids in heart transplantationClinical Transplantation, 2010
- Tacrolimus‐induced cholestatic syndrome following pediatric liver transplantation and steroid‐resistant graft rejectionPediatric Transplantation, 2005
- Tacrolimus or Cyclosporine: Which Is the Better Partner for Mycophenolate Mofetil in Heart Transplant Recipients?Transplantation, 2004
- Ethnic Disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppressionTransplantation, 2002
- A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction EquationAnnals of Internal Medicine, 1999
- Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles.Journal of Clinical Investigation, 1993
- Cyclosporine-Induced Sympathetic Activation and Hypertension after Heart TransplantationNew England Journal of Medicine, 1990